Acousia Therapeutics to present its clinical Phase 2 PROHEAR study on hearing loss treatment candidate ACOU085 at upcoming conferences

Acousia Therapeutics GmbH Massachusetts Germany United Kingdom United States of America

 

View original content:https://www.prnewswire.co.uk/news-releases/acousia-therapeutics-to-present-its-clinical-phase-2-prohear-study-on-hearing-loss-treatment-candidate-acou085-at-upcoming-conferences-302218881.html